Search

Your search keyword '"Marshall L. Spiegel"' showing total 2 results
Start Over Author "Marshall L. Spiegel" Publisher american society of clinical oncology (asco)
2 results on '"Marshall L. Spiegel"'

1. Effects of FDA drug approvals on a thoracic oncology program’s clinical trial enrollment in 2015

Author

Blanca A. Ledezma, Jonathan W. Goldman, Alice Huai-Yu Li, Meghan Brennan, Karolyn K. Morris, Melody A. Mendenhall, Lauren Sauer, Deborah Jean Lee Wong, James M. Carroll, D. Andrew Tucker, Paulina J Linares, Marshall L. Spiegel, Edward B. Garon, Carlos R. Adame, Courtney L. Wells, Jennifer L. Strunck, Sina Famenini, Christina DiLauro Abaya, Ariana R. Hardy, and Aaron Lisberg

Subjects
Oncology, Cancer Research, medicine.medical_specialty, biology, business.industry, respiratory tract diseases, Clinical trial, Internal medicine, Programmed cell death 1, Thoracic Oncology, medicine, biology.protein, Drug approval, Non small cell, business
Abstract

e20662Background: The 6 FDA drug approvals for non-small cell lung cancer (NSCLC) in 2015 included 2 programmed cell death protein 1 (PD-1) inhibitors and a 3rd generation (gen) epidermal growth fa...

Published
2016
Full Text
View/download PDF

2. Evaluating causes of screen failure (SF) in non-small cell lung cancer (NSCLC) clinical trials requiring specific biomarker (BioM) results for enrollment

Author

Danielle J. Nameth, Phillip A. Abarca, Edward B. Garon, Olayinka Oshodi, Carmel Diamant, Jonathan W. Goldman, Brian R. Wolf, Steven R. Carrasco, Blanca A. Ledezma, Carlos R. Adame, John M. Horton, Deborah Jean Lee Wong, Melody A. Mendenhall, Darren D. Pan, Marshall L. Spiegel, William Sago, Sarah M. Rosales, Daria Gaut, and Mary Han

Subjects
Clinical trial, Oncology, Cancer Research, medicine.medical_specialty, business.industry, Internal medicine, SCREEN FAILURE, medicine, Biomarker (medicine), non-small cell lung cancer (NSCLC), medicine.disease, business
Abstract

7517 Background: Trials for NSCLC have increasingly targeted specific molecular abnormalities. This approach has led to approval of multiple drugs based on results in specific BioM populations prio...

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results